Clinical Trial Update: A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing daily valacyclovir to placebo for suppression of genital herpes (HSV-2) in newly diagnosed patients; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• VALTREX (valacyclovir hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Genitalis | Phase 4 | Status: COMPLETED | Results posted: 2019-02-15